
Intervet UK is one of the largest animal health companies in the country. We research and develop, manufacture and market products for the prevention and treatment of health problems in a variety of farm animals, including poultry, pigs, cattle, sheep, goats, fish and companion animals like cats, dogs, horses and domestic rabbits. Products range from vaccines and antimicrobials to parasite control products and other health supplements.
Based in Milton Keynes, our activities include marketing and sales, production and research and development. Including our field-based marketing personnel, we currently employ around 300 persons.
Intervet UK is part of Intervet International bv, which specializes in the development, manufacture and sale of animal health products. With global revenues in 2006 of €1,125 million, Intervet is the world’s third largest animal health company.
With our comprehensive research and manufacturing capabilities, and a distribution network covering more than 100 countries, Intervet and its subsidiaries employ more than 5,300 people and operate in over 50 countries. Across this entire infrastructure, our single-minded ambition is to be viewed as professionals working for professionals in the animal health industry.
Intervet is part of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough’s vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders served by its approximately 50,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
For more information, visit www.intervet.co.uk